Company Filing History:
Years Active: 2018-2025
Title: Tinoush Moulaei: Innovator in Viral Inhibition
Introduction
Tinoush Moulaei is a notable inventor based in College Park, MD (US). He has made significant contributions to the field of viral inhibition through his innovative research and inventions. With a total of 4 patents, Moulaei has established himself as a key figure in his area of expertise.
Latest Patents
Among his latest patents, Moulaei has developed modified griffithsin polypeptides. These inventions comprise the amino acid sequence of SEQ ID NO: 1, along with corresponding nucleic acids, vectors, cells, fusion proteins, constructs, conjugates, and methods aimed at inhibiting viral infection. His work in this area is crucial for advancing therapeutic strategies against viral diseases.
Career Highlights
Moulaei has worked with prestigious organizations, including the National Institutes of Health, a component of the US Department of Health & Human Services, and the University of Louisville Research Foundation, Inc. His experience in these institutions has allowed him to collaborate with leading experts in the field.
Collaborations
Some of his notable coworkers include Barry R O'Keefe and Kenneth E Palmer. Their collaborative efforts have contributed to the success of his research and inventions.
Conclusion
Tinoush Moulaei's innovative work in the field of viral inhibition showcases his dedication to advancing medical science. His patents and collaborations reflect his significant impact on the industry.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.